Cancer Family
Sarcoma
CI-CAN-00000344SARExplore in graph →
635 active trials17 approved drugs182 evidence items
- NCIt
- C9118
- OncoTree
- SARCNOS
- DOID
- 1115
- MeSH
- D012509
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000344SARExplore in graph →
Clinical trials
2,688 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (367)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01786226 | Mifepristone to Treat Uterine Fibroids | terminated | Phase 2 / Phase 3 | 220 | Mediterranea Medica S. L.OTHER | 1 | Sep 5, 2014 | clinicaltrials |
| NCT01002092 | A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma | unknown | Phase 2 | 160 | Shandong Simcere-Medgenn Bio-pharmaceutical Co., LtdINDUSTRY | 1 | Sep 3, 2014 | clinicaltrials |
| NCT00516295 |
| Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma |
| completed |
| Phase 2 |
| 7 |
| National Cancer Institute (NCI)NIH |
| 1 |
| Sep 2, 2014 |
| clinicaltrials |
| NCT00093509 | MRI Sarcoma Non Invasive Thermometry | completed | Phase 1 / Phase 2 | 15 | Mark DewhirstOTHER | 1 | Sep 1, 2014 | clinicaltrials |
| NCT00005042 | SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma | completed | Phase 2 | — | AIDS Malignancy ConsortiumNETWORK | 1 | Aug 29, 2014 | clinicaltrials |
| NCT00075777 | Valproic Acid in Treating Patients With Kaposi's Sarcoma | completed | N/A | 19 | AIDS Malignancy ConsortiumNETWORK | 1 | Aug 29, 2014 | clinicaltrials |
| NCT00450320 | Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma | completed | Phase 1 | 7 | AIDS Malignancy ConsortiumNETWORK | 1 | Aug 29, 2014 | clinicaltrials |
| NCT01451424 | Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids | completed | Phase 2 | 40 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 29, 2014 | clinicaltrials |
| NCT00544778 | Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma | terminated | Phase 2 | 7 | City of Hope Medical CenterOTHER | 0 | Aug 28, 2014 | clinicaltrials |
| NCT00958893 | An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext | terminated | Phase 2 | 4 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 25, 2014 | clinicaltrials |
| NCT00920738 | Metabolic Syndrome in Childhood Cancer Survivors | completed | — | 512 | University of MinnesotaOTHER | 1 | Aug 22, 2014 | clinicaltrials |
| NCT00683917 | Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids | terminated | Phase 2 | 10 | Repros Therapeutics Inc.INDUSTRY | 2 | Aug 21, 2014 | clinicaltrials |
| NCT00702702 | Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 56 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00735553 | Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 77 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00737282 | Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids | terminated | Phase 3 | 175 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00785356 | Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 8 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00853567 | Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 71 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT01069120 | Safety of 25 and 50 mg Proellex® in the Treatment of Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 27 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00444379 | Anti-Retrovirals for Kaposi's Sarcoma(ARKS) | completed | Phase 4 | 224 | University of California, San FranciscoOTHER | 1 | Aug 20, 2014 | clinicaltrials |
| NCT00565721 | A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis | completed | Phase 2 | 33 | GE HealthcareINDUSTRY | 1 | Aug 18, 2014 | clinicaltrials |
| NCT00002641 | Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma | completed | Phase 3 | 350 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 13 | Aug 8, 2014 | clinicaltrials |
| NCT00003750 | Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors | completed | Phase 1 | 28 | Children's Oncology GroupNETWORK | 3 | Aug 8, 2014 | clinicaltrials |
| NCT00410462 | Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma | unknown | Phase 2 | 118 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Aug 8, 2014 | clinicaltrials |
| NCT01189253 | Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma | terminated | Phase 2 / Phase 3 | 133 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 13 | Aug 8, 2014 | clinicaltrials |
| NCT00003793 | Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma | completed | — | 294 | Children's Oncology GroupNETWORK | 3 | Aug 5, 2014 | clinicaltrials |
| NCT00003937 | Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma | completed | Phase 3 | 253 | Children's Oncology GroupNETWORK | 6 | Aug 5, 2014 | clinicaltrials |
| NCT00003234 | Vinorelbine in Treating Children With Recurrent or Refractory Cancers | completed | Phase 2 | 50 | Children's Oncology GroupNETWORK | 7 | Jul 28, 2014 | clinicaltrials |
| NCT00002804 | Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma | completed | Phase 2 | 43 | Children's Oncology GroupNETWORK | 3 | Jul 25, 2014 | clinicaltrials |
| NCT00132704 | An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation | completed | — | 149 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 24, 2014 | clinicaltrials |
| NCT00740597 | Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma | terminated | Phase 2 | 1 | City of Hope Medical CenterOTHER | 1 | Jul 11, 2014 | clinicaltrials |
| NCT00882258 | Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids | completed | Phase 2 | 144 | Repros Therapeutics Inc.INDUSTRY | 1 | Jul 8, 2014 | clinicaltrials |
| NCT00742924 | Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma | completed | Phase 1 | 24 | Children's Oncology GroupNETWORK | 4 | Jul 4, 2014 | clinicaltrials |
| NCT00874029 | Laparoscopic Radiofrequency Ablation (RFA) of Symptomatic Uterine Fibroids(Halt) | completed | N/A | 137 | Acessa Health, Inc.INDUSTRY | 3 | Jul 3, 2014 | clinicaltrials |
| NCT00874302 | Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms | withdrawn | Phase 3 | 0 | Repros Therapeutics Inc.INDUSTRY | 2 | Jun 27, 2014 | clinicaltrials |
| NCT00020566 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma | unknown | Phase 3 | 1,200 | University of LeicesterOTHER | 5 | Jun 24, 2014 | clinicaltrials |
| NCT00141765 | Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers | completed | Phase 2 | 25 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jun 20, 2014 | clinicaltrials |
| NCT00408655 | Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 38 | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2014 | clinicaltrials |
| NCT00918281 | Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection | completed | Phase 2 | 70 | GE HealthcareINDUSTRY | 1 | Jun 9, 2014 | clinicaltrials |
| NCT00188175 | IMRT Lower Limb Soft Tissue Sarcoma | completed | Phase 2 | 59 | University Health Network, TorontoOTHER | 1 | Jun 3, 2014 | clinicaltrials |
| NCT00245102 | Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma | completed | Phase 2 | 147 | National Cancer Institute (NCI)NIH | 1 | May 23, 2014 | clinicaltrials |
| NCT00002863 | Cryosurgery in Treating Patients With Soft Tissue Sarcoma | terminated | Phase 1 | 19 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00295945 | Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic Cancer | completed | — | 240 | University of California, San FranciscoOTHER | 1 | May 20, 2014 | clinicaltrials |
| NCT00217620 | S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas | completed | Phase 2 | 51 | National Cancer Institute (NCI)NIH | 1 | May 15, 2014 | clinicaltrials |
| NCT00944476 | Application of Magnetic Resonance Fat-Free Imaging | terminated | — | 2 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 15, 2014 | clinicaltrials |
| NCT00631631 | Mifamurtide (L-MTP-PE) for High-Risk Osteosarcoma | completed | — | 205 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | May 14, 2014 | clinicaltrials |
| NCT00937495 | Vorinostat and Bortezomib in Treating Patients With Advanced Soft Tissue Sarcoma | completed | Phase 2 | 16 | National Cancer Institute (NCI)NIH | 1 | May 14, 2014 | clinicaltrials |
| NCT00579501 | Safety and Efficacy Study of Trabectedin for the Treatment of Localized Myxoid / Round Cell Liposarcoma | completed | Phase 2 | 29 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 3 | May 7, 2014 | clinicaltrials |
| NCT00521092 | Sunitinib Malate in Treating East African Patients With Kaposi Sarcoma | withdrawn | Phase 2 | 0 | National Cancer Institute (NCI)NIH | 0 | May 5, 2014 | clinicaltrials |
| NCT00330421 | Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07) | completed | Phase 2 | 15 | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2014 | clinicaltrials |
| NCT01631903 | Extension of Study ZPV-200 | completed | Phase 2 | 48 | Repros Therapeutics Inc.INDUSTRY | 1 | Apr 16, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Sep 5, 2014source: clinicaltrials